Allogene Therapeutics Inc
NASDAQ:ALLO
Wall Street
Price Targets
ALLO Price Targets Summary
Allogene Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for ALLO is 9.223 USD with a low forecast of 3.03 USD and a high forecast of 14.7 USD.
ALLO Last Price Targets
Allogene Therapeutics Inc
The latest public price target was made on May 16, 2024 by Debjit Chattopadhyay from H.C. Wainwright , who expects ALLO stock to rise by 393% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.
Analyst | Price Target | Date | Article |
---|---|---|---|
Debjit Chattopadhyay
H.C. Wainwright
|
9
USD
Upside 393% |
8 months ago
May 16, 2024
|
Allogene (ALLO) PT Lowered to $9 at H.C. Wainwright
StreetInsider
|
Kalpit Patel
B.Riley Financial
|
7
USD
Upside 284% |
8 months ago
May 14, 2024
|
Allogene (ALLO) PT Lowered to $7 at B.Riley
StreetInsider
|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ALLO's stock price target?
Price Target
9.223
USD
According to Wall Street analysts, the average 1-year price target for ALLO is 9.223 USD with a low forecast of 3.03 USD and a high forecast of 14.7 USD.
What is Allogene Therapeutics Inc's Revenue forecast?
Projected CAGR
392%
The compound annual growth rate of Allogene Therapeutics Inc's revenue for the next 4 years is 392%.